Skip to main content

First COVID-19 Reinfection in U.S.

First Case of COVID-19 Reinfection in the United States

    Contrary to popular belief, it is possible to become infected with the coronavirus more than once. This summer, the United States experienced its first case of COVID-19 reinfection and fifth case worldwide. The four other reinfection cases occurred in Hong Kong, the Netherlands, Belgium, and Ecuador. A recent study published on October 12, 2020 in The Lancet Infectious Diseases, presents a detailed case report and discussion of the American individual who experienced two separate COVID-19 infections.

    About the Patient

    The reinfected patient was a 25 year old male from Washoe County, Nevada. The patient first tested positive for COVID-19 on April 18, 2020 with mild symptoms (sore throat, cough, headache, nausea, and diarrhea) beginning in April. He had no underlying conditions or indications of a compromised immune system. The patient recovered after 9 days but began experiencing more severe symptoms (fever, headache, dizziness, nausea, diarrhea, and shortness of breath) late May. The patient was given oxygen and tested positive for COVID-19 again on June 5, 2020. He has since recovered. 

Timeline of Symptom Onset
Timeline of Symptom Onset

    Increased symptom severity in reinfection only occurred in the United States and Belgium whereas cases from the Netherlands, Hong Kong, and Ecuador showed no difference in symptom severity. Researchers believe the more severe symptoms during second infection may be a result of 3 different situations. First, the patient could have had a higher viral dose in the secondary infection. Second, the version of the virus in reinfection could have been more virulent, or harmful in its effects on the patient. Third, antibodies developed from initial infection may have made secondary infection worse. This instance has been seen previously with SARS-CoV2 betacoronaviruses.

Implications

    The study suggests that possible variations of the virus could decrease the efficacy of developing vaccines. A vaccine developed for one version of the virus may not be effective against another version of the virus. However, further research needs to be conducted before conclusions can be made. 

    This incidence of reinfection also shows that it is possible for people who have previously tested positive for COVID-19 to be infected again. As a result, those who have been infected with COVID-19 should continue to take serious hygienic precautions as well as social distance and wear masks. Getting the coronavirus once and recovering from infection doesn't make you invincible or immune to reinfection.

Sources

1. Tillett RL, Sevinsky JR, Hartley PD, et al. Genomic evidence for reinfection with SARS-CoV-2: a case study. Lancet Infect Dis. Published online October 12 2020. doi: 10.1016/S1473-3099(20)30764-7

Comments

Popular posts from this blog

Efficacy of Masks

Do Wearing Masks Really Prevent Coronavirus            For weeks, U.S. health authorities discouraged healthy Americans from wearing masks, believing they would do more harm than good. However, other countries such as China and South Korea have required all citizens to wear a mask when entering a public setting to prevent the spread of the coronavirus. But really how effective are these masks against the coronavirus? On April 3rd, Nature Medicine published an article describing their findings based off an experiment testing the efficacy of surgical face masks against coronavirus, influenza virus and rhinovirus.   Study Findings      Their results demonstrated that surgical masks were largely effective in reducing coronavirus transmission through respiratory droplets as well as aerosol particles. Three out of ten people who did not wear a mask were infected with the coronavirus through droplet particles. Out of eleven people w...

Breakthrough Infections

 COVID-19 Breakthrough Infections     As of August 2021, a little over 50% of the U.S. population has been fully vaccinated against COVID-19. However, despite the increasing number of vaccinated individuals and high efficacy of the vaccines, rare breakthrough cases have occurred. With the reports of breakthrough cases, or instances when people who are fully vaccinated get infected with COVID-19, many questions have arisen. How common are breakthrough infections? What are the symptoms? How severe are the cases? These questions are addressed in a peer-reviewed study investigating breakthrough cases among healthcare workers in Israel. The study was recently published in the New England Journal of Medicine on July 28, 2021.  About the Study     The study setting took place in the Sheba Medical Center, which is the largest medical center in Israel staffed with 12,586 healthcare workers. By April 28, 2021, 11,453 workers (91%) had been fully vaccinated with the ...

Plasma for COVID-19 treatment

FDA Authorizes Plasma for COVID-19 Treatment                     COVID-19, which has been spreading across the globe since March, has affected the lives of Americans for over six months. Many people, including the President, are eager to eliminate the virus after a dreadful 6 months of rising cases and quarantine. To their dismay, hopes of eliminating the virus by Easter and then by August, seemed to turn into an unreachable dream for Americans. With cases rising and no sure vaccine or treatment for the virus, a future without COVID-19 seemed further and further away. Yet, this Sunday on August 23, 2020, the U.S. Food and Drug Administration authorized the first treatment for COVID-19: convalescent plasma. While the plasma has only been authorized for emergency use, many people see this authorization as progress towards eliminating the virus. However, others believe that the plasma is not as effective, and that the FDA was pres...